Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Ann Neurol. 2022 Nov 22;93(1):184–195. doi: 10.1002/ana.26542

Table 1.

Distribution of synucleinopathy by Braak Lewy body stage and basic demographics

Lewy body
stage*
(no. of patients)
Age at onset of
motor symptoms
(yr)
mean±SD
Age at onset
of dementia
(yr)
mean±SD
Duration of
motor symptoms
(yr)
mean±SD
Age at death
(yr)
mean±SD
PDND (37) 56.6 ± 14.6 - 17.0 ± 9.7 73.4 ± 11.5
 Braak 3 (5) 62.5 ± 11.1 - 12.1 ± 5.8 74.6 ± 6.7
 Braak 4 (7) 63.9 ± 13.9 - 13.7 ± 9.8 77.6 ± 9.0
 Braak 5 (15) 56.1 ± 12.9 - 19.0 ± 10.6 75.1 ± 8.8
 Braak 6 (10) 49.4 ± 17.1 - 18.7 ± 9.7 68.0 ± 16.9
 
PDD (114) 62.4 ± 9.6 74.1 ± 6.8 16.4 ± 6.5 78.8 ± 6.0
 Braak 3 (1) 56 73 19 75
 Braak 4 (6) 60.1 ± 1.6 72.5 ± 7.0 16.1 ± 7.3 76.2 ± 6.1
 Braak 5 (34) 62.0 ± 11.0 73.1 ± 7.7 16.1 ± 7.3 77.9 ± 6.1
 Braak 6 (73) 63.0 ± 9.4 74.7 ± 6.4 16.5 ± 6.4 79.5 ± 5.9
 
DLB (14) 64.1 ± 8.5 64.9 ± 8.3 10.1 ± 4.1 74.2 ± 6.5
 Braak 3 (1) 64 64 4 68
 Braak 4 (1) 68 68 11 79
 Braak 5 (6) 61.9 ± 11.8 63.8 ± 11.7 12.4 ± 3.9 74.3 ± 9.3
 Braak 6 (6) 65.6 ± 6.0 65.7 ± 6.3 8.6 ± 3.6 74.2 ± 3.7
*

Lewy body stage according to Braak H, Del Tredici K, Rub U et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003; 24:197–211

indicates significant difference (prior to correction for multiple comparisons) between PDND and combined dementia group, p < 0.05

indicates significant difference between PDD and DLB, p < 0.05